Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Filings indexed 1,619 across all filing types
Latest filing 2014-03-28 Management Reports
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
102年度應收帳款周轉率
Management Reports Classification · 85% confidence The document contains financial ratios related to accounts receivable turnover and average collection days for two fiscal years (101 and 102), along with an explanation for significant changes. The content is brief (335 characters) and focuses on financial metrics and management commentary on changes. It does not present a full financial report or comprehensive financial statements, nor does it appear to be an announcement or certification. Given the nature of the content—management's explanation of financial results and business trends—it aligns best with a Management Reports (MDA) filing type.
2014-03-28 Chinese
公告本公司董事會決議102年度虧損撥補案
Board/Management Information Classification · 95% confidence The document is a short announcement from the company's board regarding the resolution on the 102nd fiscal year's loss compensation plan. It includes details about dividend distribution, board and employee bonuses, and other related financial decisions, all indicating a board resolution. The document length is only 715 characters, and it is a formal announcement of a board decision rather than a full report or detailed financial statement. Therefore, it fits best under Board/Management Information (MANG).
2014-03-17 Chinese
102年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 95% confidence The document text is a detailed announcement of dividend distribution information for a company, including dividend amounts, dates, and related notes. It does not contain a full annual or interim financial report, nor is it a presentation or management discussion. The content focuses specifically on dividend amounts and payment details, which aligns with the definition of a Notice of Dividend Amount (DIV). The document length is short (1833 characters), but it contains substantive dividend distribution data rather than just an announcement of a report publication. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2014-03-17 Chinese
公告本公司103年3月17日董事會通過之重要議案
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 103/03/17 (Taiwan calendar year, equivalent to 2014) reporting on important resolutions passed at the board meeting. It lists several items including investment decisions, cash capital increase, approval of the 102 fiscal year business report and financial statements, loss appropriation, shareholder meeting agenda corrections, review of shareholder proposals, and internal control statement. The document is short (784 characters) and serves as a summary announcement of board meeting decisions rather than the full reports themselves. It does not contain detailed financial statements or comprehensive analysis. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement of board resolutions and related corporate actions without the full report attached or included.
2014-03-17 Chinese
更正公告本公司董事會決議召開103年股東常會相關事宜
AGM Information Classification · 95% confidence The document is a public announcement from a listed company regarding the correction of the board of directors' resolution to convene the 103rd Annual General Meeting (AGM). It includes details such as the date and location of the AGM, agenda items including reports, approvals, discussions, and elections, as well as procedural information about proposal submissions and nomination periods. The content is focused on the announcement and arrangements for the AGM rather than the AGM materials or the report itself. The document length is short (1052 characters), and it serves as a formal notice about the AGM meeting details. Therefore, it fits the category of AGM Information (AGM-R).
2014-03-17 Chinese
本公司辦理現金增資案
Capital/Financing Update Classification · 95% confidence The document is a short announcement (884 characters) from a company (3164 景岳) regarding a cash capital increase (現金增資案). It includes details such as board resolution date, number of shares issued, issue price, and purpose of the capital increase. There are no financial statements or detailed financial analysis present. The document is an update on a financing activity, specifically a capital increase, which fits the category of Capital/Financing Update (CAP). It is not a full report or an announcement of a report publication, nor is it a regulatory filing or other category. Therefore, the appropriate classification is CAP with high confidence.
2014-03-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.